Groceries Plus Multi-Component Lifestyle Intervention for Adults With Hypertension and Type 2 Diabetes
Launched by JOHNS HOPKINS UNIVERSITY · Apr 8, 2025
Trial Information
Current as of May 30, 2025
Recruiting
Keywords
ClinConnect Summary
The Groceries Plus study is looking at how a healthy diet can help adults with high blood pressure and type 2 diabetes manage their conditions better. Many people with these health issues don’t eat enough fresh fruits and vegetables, which can lead to low levels of important nutrients. This study aims to see if offering support to eat healthier and manage weight can help lower blood pressure and blood sugar levels. The trial is open to adults aged 18 and older who live in certain areas of Baltimore with limited access to healthy food. Participants will be divided into two groups: one will receive advice on how to shop for healthy foods, while the other will get more personalized coaching.
To be part of the study, you should have been diagnosed with type 2 diabetes, have a specific range of blood pressure, and be living in a designated area with limited access to healthy foods. However, there are some criteria that would exclude you, such as having very low blood sugar levels recently or taking certain diabetes medications. If you join the study, you'll participate for six months and learn how to make healthier food choices that could improve your health. This is a great opportunity for those who want to take control of their health with support from the research team.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18 years or older
- • Diabetes Mellitus Type 2 defined by: self-reported type 2 diabetes diagnosis, or HbA1c\>=6.5%, or treatment of diabetes with diabetes medications(s)
- • Baseline systolic BP 120-159 mmHg (with or without medications.)
- • Serum potassium level \>3.0 and \<5 mmol/L,
- • Estimated glomerular filtration rate (eGFR) \>=45 mL/min/1.73m2.
- • Willing and able to complete required procedures in English.
- • Living in Healthy Food Priority Area in Baltimore; the US Department of Agriculture (USDA) defined low income, low access areas, or census blocks with area deprivation index (ADI) 60 and above (State Decile\>=6.)
- Exclusion Criteria:
- • Hypoglycemia requiring hospitalization or the assistance of another person in the last 6 months
- • Cardiovascular event within 6 months
- • On diabetes or weight loss medications such as glucagon-like peptide 1 (GLP-1), GLP-1/glucose-dependent insulin-releasing peptide (GIP), insulin, or any combination of these medications
- • HbA1c ≥ 10%
- • Type 1 diabetes
- • Baseline systolic BP \< 100 mmHg
- • Weight \>400 lbs due to the maximum weight on study scale
- • Chronic disease that might interfere with trial participation
- • Current participation in another clinical trial that might affect blood pressure, weight loss, diabetes, or ability to adhere to study procedures
- • Current participation in program with conflicting dietary guidance (i.e., meal replacement or keto diets)
- • Unwillingness or inability to adopt a DASH-like diet
- • Planning to leave area in the next 6 months
About Johns Hopkins University
Johns Hopkins University, a prestigious research institution located in Baltimore, Maryland, is renowned for its commitment to advancing medical science and public health through innovative clinical trials. With a rich history of groundbreaking research and a multidisciplinary approach, the university's clinical trial initiatives focus on translating scientific discoveries into effective treatments and interventions. Leveraging state-of-the-art facilities and a collaborative network of experts, Johns Hopkins University conducts rigorous clinical studies that aim to improve patient outcomes and address critical health challenges. Its dedication to ethical standards and participant safety underscores its role as a leader in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Baltimore, Maryland, United States
Patients applied
Trial Officials
Jessica Yeh, PhD
Principal Investigator
Johns Hopkins University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported